Literature DB >> 21893882

Impact of alert specifications on clinicians' adherence.

M M Langemeijer1, L W Peute, M W M Jaspers.   

Abstract

Computerized alerts provided by health care information systems have been shown to enhance clinical practice. However, clinicians still override more than half of the alerts. This indicates that certain aspects of alerts need improvement to fulfill their purpose of supporting clinicians in decision making. This paper reports on a systematic review on studies evaluating alert specifications and their impact on clinicians' alert adherence. The review revealed that use of colors and icons to distinguish different alert severity levels and presenting high severity alerts in an interruptive fashion increases clinicians adherence to alert recommendations. Alert message contents that lack clinical importance or provide incorrect texts increase alert non-adherence. Few studies have yet focused on the impact of alert specifications on clinicians' adherence. A research agenda is needed on alert specifications and their impact on clinicians' adherence in order to develop alerts that truly support clinician decision making.

Mesh:

Year:  2011        PMID: 21893882

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  3 in total

1.  Drug interaction alert override rates in the Meaningful Use era: no evidence of progress.

Authors:  A D Bryant; G S Fletcher; T H Payne
Journal:  Appl Clin Inform       Date:  2014-09-03       Impact factor: 2.342

2.  An automated clinical alert system for newly-diagnosed atrial fibrillation.

Authors:  David A Cook; Felicity Enders; Pedro J Caraballo; Rick A Nishimura; Farrell J Lloyd
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

3.  From assessment to improvement of elderly care in general practice using decision support to increase adherence to ACOVE quality indicators: study protocol for randomized control trial.

Authors:  Saeid Eslami; Marjan Askari; Stephanie Medlock; Derk L Arts; Jeremy C Wyatt; Henk C P M van Weert; Sophia E de Rooij; Ameen Abu-Hanna
Journal:  Trials       Date:  2014-03-19       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.